Shire, DOJ Reach $350M Deal In Dermagraft FCA Investigation
By Melissa Daniels ( August 2, 2016, 10:05 PM EDT) -- Biotech company Shire on Tuesday told investors that it reached a tentative $350 million settlement with the U.S. Department of Justice to settle False Claims Act violations and Medicaid-related claims over the sales and marketing practices relating to Dermagraft....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.